Related content

Effects of triiodothyronine replacement therapy in patients with chronic stable heart failure and low‐triiodothyronine syndrome: a randomized, double‐blind, placebo‐controlled study

By  

ESC HEART FAILURE, Vol. 2, Iss. 1, 2015-03 ,pp. : 5-11

John Wiley & Sons Inc

Access to resources Recommend Favorite

Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome – a pilot study

By Tuteja Ashok K.   Fang John C.   Al-Suqi Manal   Stoddard Gregory J.   Hale Devon C.  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 10, 2012-10 ,pp. : 1159-1164

Informa Healthcare

Access to resources Recommend Favorite

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

By Nyhlin H.   Bang C.   Elsborg L.   Silvennoinen J.   Holme I.   Rüegg P.   Jones J.   Wagner A.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study

By Penna I.A.A.  

Human Reproduction, Vol. 20, Iss. 9, 2005-09 ,pp. : 2396-2401

Oxford University Press

Access to resources Recommend Favorite

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study

By Tang Thomas   Glanville Julie   Hayden Catherine J.   White Davinia   Barth Julian H.   Balen Adam H.  

Human Reproduction, Vol. 21, Iss. 1, 2006-01 ,pp. : 80-89

Oxford University Press

Access to resources Recommend Favorite